Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prospective Study of Rapamycin for the Treatment of SLE (Rapamune)

This study has been completed.
Information provided by (Responsible Party):
Andras Perl, MD, Ph.D, State University of New York - Upstate Medical University Identifier:
First received: October 23, 2008
Last updated: October 12, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)